Biotech

All Articles

ReNeuron leaving purpose swap after skipping fundraising goal

.ReNeuron has joined the long checklist of biotechs to leave Greater london's goal stock exchange. T...

MBX apply for IPO to take challenger to Ascendis into phase 3

.MBX Biosciences has included in the current spurt of IPO filings. The biotech, which filed its docu...

FDA extends probe into Lykos' MDMA tests: WSJ

.For Lykos Rehabs as well as the provider's would-be MDMA-assisted therapy for post-traumatic stress...

Gene editor Volume laying off 131 laborers

.Only days after gene editor Tome Biosciences introduced concealed functional cuts, a more clear ima...

Repare lays off 25% of personnel as biotech halts preclinical R&ampD

.Repare Therapy is giving up a quarter of its labor force as the oncology biotech scales back its ow...

J &amp J apply for FDA approval of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually taken another step towards noticing a return on its $6.5 billion ...

Gain's stage 1 gain leads means to verify Parkinson's drug's worth

.Increase Rehabs has specified its own direct showing the performance of its own Parkinson's health ...

Actinogen records brand new phase 2 data to save depression medicine

.Actinogen Medical's hopes-- as well as sell cost-- have actually recoiled somewhat from previously ...

Pfizer and also Main incorporate Quotient to multibillion-dollar equation

.Front Runner Pioneering and Pfizer have incorporated Quotient right into their 10-program collabora...

Bayer markers $547M treaty to push boundaries of noncoding RNA

.Bayer managers were eager to worry to Fierce this summer season that the German pharma titan's appe...